David L. Hotchkin
5 Papers
1 Citations
David L. Hotchkin is an academic researcher. The author has contributed to research in topics: Internal medicine & Idiopathic pulmonary fibrosis. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases
Vincent Cottin,Nikhil Hirani,David L. Hotchkin,Anoop M. Nambiar,Takashi Ogura,Maria Otaola,Dirk Skowasch,Jong Sun Park,Hataya K. Poonyagariyagorn,Wim A. Wuyts,Athol U. Wells +10 more
TL;DR: Although these conditions are rare, a proportion of patients with interstitial lung diseases (ILDs) may develop a progressive-fibrosing phenotype, and identification of these patients is crucial, and requires a multidisciplinary approach, to ensure optimal diagnosis and management.
Associations between resources and practices of ILD centers and outcomes in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry
Tejaswini Kulkarni,Megan L. Neely,Anne S. Hellkamp,Amy Case,Daniel A. Culver,Kalpalatha K. Guntupalli,Shaun Bender,Craig S Conoscenti,Laurie D. Snyder,Albert Baker,Scott Beegle,John A. Belperio,Rany Condos,Francis Cordova,Daniel F. Dilling,John FitzGerald,Leann Silhan,Kevin R. Flaherty,Kevin F. Gibson,Mridu Gulati,Nishant Gupta,David L. Hotchkin,Tristan J. Huie,Robert J. Kaner,Hyun Koo Kim,Lisa Lancaster,Mark P. Steele,Joseph A. Lasky,Doug Lee,Timothy Liesching,Randolph J. Lipchik,Jason Lobo,Tracy Luckhardt,Joao A. de Andrade,Yolanda N. Mageto,Howard J. Huang,Prema R. Menon,Andrew Namen,Justin M. Oldham,Tessy Paul,David Zhang,Anna J. Podolanczuk,David J. Lederer,Nina Patel,Mary K. Porteous,Mary Elizabeth Kreider,Rishi Raj,Paul Mohabir,Murali Ramaswamy,Tonya D. Russell,Paul Sachs,Zeenat Safdar,Shirin Shafazand,Marilyn K. Glassberg,Ather Siddiqi,Wael Asi,Barry Sigal,Mary E. Strek,Sally Suliman,Jesse Roman,Jeremy Tabak,Rajat Walia,Timothy P.M. Whelan +62 more
TL;DR: In this paper , the authors used data from the IPF-PRO Registry, an observational registry of patients with idiopathic pulmonary fibrosis (IPF) managed at sites across the US, to examine associations between the characteristics of the enrolling sites and patient outcomes.
Clarifying the Pathway to an Accurate Diagnosis of Interstitial Lung Disease: Results from a Modified Delphi Survey in the US
A. Hajari Case,Scott Beegle,David L. Hotchkin,Thomas Kaelin,H.J. Kim,Anna J. Podolanczuk,M. Ramaswamy,Carlos Remolina,F. Salvatore,Chai-Xia Tu,Timothy P.M. Whelan,Joao A. de Andrade +11 more
- 01 May 2022
Defining the pathway to timely diagnosis and treatment of interstitial lung disease: a US Delphi survey.
Amy Case,Scott Beegle,David L. Hotchkin,Thomas Kaelin,Hyun Joo Kim,Anna J. Podolanczuk,Murali Ramaswamy,Carlos Remolina,Mary M Salvatore,Conan Tu,Joao A. de Andrade +10 more
TL;DR: These findings clarify the most common issues that should merit further evaluation for ILD and help define the steps for timely, accurate diagnosis and appropriate collaborative specialty management of patients with ILD.
Clinical Outcomes of Patients with Combined Idiopathic Pulmonary Fibrosis and Emphysema in the IPF-PRO Registry
Hyun Koo Kim,Laurie D. Snyder,Megan L. Neely,Anne S. Hellkamp,David L. Hotchkin,Lake Morrison,Shaun Bender,Thomas Leonard,Daniel A. Culver +8 more
TL;DR: In this paper , the authors assess the impact of concomitant emphysema on outcomes in patients with idiopathic pulmonary fibrosis (IPF) using Cox proportional hazards models.